GLP 1 drugs

Quitting GLP-1 drugs triggers rapid regain, but 25% of weight loss may last

by University of Cambridge edited by Stephanie Baum, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain A year after stopping taking weight-loss drugs such as Ozempic and Wegovy, people regain—on average—60% of their lost weight. But beyond this, their regained weight plateaus, with individuals managing to keep off 25% of […]

Quitting GLP-1 drugs triggers rapid regain, but 25% of weight loss may last Read More »

GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people

by Ziyad Al-Aly, The Conversation edited by Lisa Lock, reviewed by Andrew Zinin  Editors’ notes  The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He

GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people Read More »

GLP-1 drugs associated with reduced need for emergency care for migraine

Drugs also related to lower use of drugs to stop, prevent attacks Meeting AnnouncementAmerican Academy of Neurology EMBARGOED FOR RELEASE UNTIL 4:00 P.M. ET, SUNDAY, MARCH 1, 2026 Highlights: For people with chronic migraine, starting GLP-1 drugs for conditions like diabetes may be associated with fewer emergency department visits. A preliminary study has found that

GLP-1 drugs associated with reduced need for emergency care for migraine Read More »

GLP-1 drugs combined with healthy lifestyle habits linked to reduced cardiovascular risk among diabetes patients

by Harvard T.H. Chan School of Public Health edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain Individuals living with type 2 diabetes (T2D) had a significantly lower risk of poor cardiovascular health when they used a GLP-1 receptor agonist (GLP-1 RA) in combination with adhering to

GLP-1 drugs combined with healthy lifestyle habits linked to reduced cardiovascular risk among diabetes patients Read More »

Scroll to Top